Ani Pharmaceuticals Inc (ANIP) returns
Ani Pharmaceuticals returns over 10 years
$1,000 invested in Ani Pharmaceuticals ten years ago was worth $1,194 at the close on October 30, 2026, with dividends reinvested: an average return of 1.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -0.9% | — | $991.05 | -0.9% |
| 3 months | -10.5% | — | $895.19 | +2.1% |
| Year to date | -8.8% | — | $912.09 | +11.7% |
| 1 year | -21.7% | — | $783.21 | +12.4% |
| 3 years | +19.0% | +6.0% | $1,190 | +88.5% |
| 5 years | +92.6% | +14.0% | $1,926 | +76.0% |
| 10 years | +19.4% | +1.8% | $1,194 | +316.6% |
Ani Pharmaceuticals return by calendar year
| Year | ANIP | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -8.8% | +11.7% | -20.5% |
| 2025 | +42.8% | +17.7% | +25.1% |
| 2024 | +0.3% | +24.9% | -24.6% |
| 2023 | +37.1% | +26.2% | +10.9% |
| 2022 | -12.7% | -18.2% | +5.5% |
| 2021 | +58.7% | +28.7% | +29.9% |
| 2020 | -52.9% | +18.4% | -71.3% |
| 2019 | +37.0% | +31.2% | +5.8% |
| 2018 | -30.1% | -4.6% | -25.6% |
| 2017 | +6.3% | +21.7% | -15.4% |
| 2016 | +34.3% | +12.0% | +22.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ANIP financials · ANIP valuation
No forecast, no recommendation. This page describes Ani Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.